Secondary Logo

Institutional members access full text with Ovid®

French-Canadian Adaptation and Validation of the Swiss Spinal Stenosis Questionnaire for Patients With Lumbar Spinal Stenosis

Marchand, Andrée-Anne, DC, MSc; Tétreau, Charles, MSc; O'Shaughnessy, Julie, DC, MSc; Descarreaux, Martin, DC, PhD

doi: 10.1097/BRS.0000000000002896
HEALTH SERVICES RESEARCH
Buy
SDC

Study Design. An observational prospective study.

Objective. The study objective was to assess the reliability and validity of the French-Canadian version (FCSSSQ) of the Swiss Spinal Stenosis questionnaire (SSSQ).

Summary of Background Data. The SSSQ is a validated disease-specific tool developed to assess pain, function, and satisfaction with care in patients with lumbar spinal stenosis (LSS).

Methods. The French-Canadian translation and adaptation of the SSSQ was completed following a four-stage approach: (1) forward translation; (2) synthesis; (3) expert committee review; and (4) testing of the questionnaire prefinal version. Psychometric properties were subsequently determined in patients who had undergone decompressive surgery for degenerative LSS. Patients completed the SSSQ adapted version, the Numerical Rating Scale, and the Oswestry Disability Index. Test-retest reliability was assessed with weighted Kappa score and intraclass correlation coefficient. Construct validity was evaluated using the Spearman correlation coefficient and responsiveness with the mean standardized response as well as the area under the receiver operating characteristic curve (AUROC). Floor and ceiling effects and internal consistency were also evaluated.

Results. Twenty-five and 50 patients were included for the adaptation and validation processes, respectively. The test-retest reliability of the FCSSSQ total score was excellent [intraclass correlation coefficient (ICC) = 0.996; 95% confidence interval (95% CI) 0.938–0.982]. High Spearman correlation coefficients were also found between the total FCSSSQ score and the leg pain Numerical Rating Scale (NRS, 0.801), back pain NRS (0.705), and the Oswestry Disability Index (ODI, 0.825) scores. External responsiveness analysis was satisfactory with an AUROC of 0.875 (95% CI 0.744–1.0). The lowest FCSSSQ possible score was observed in five patients (10%), whereas no patients reported the highest possible score. The Cronbach α coefficient ranged from 0.810 to 0.945 indicating good to excellent internal consistency.

Conclusion. The French-Canadian version of the SSSQ is a reliable and valid questionnaire consistent with the original English version. This new version will help French-speaking clinicians and scientists document changes in condition and treatment satisfaction in patients with LSS.

Level of Evidence: 2

The Swiss Spinal Stenosis Questionnaire is a tool for patients with lumbar spinal stenosis. In this study, we propose a French-Canadian adapted version that is reliable and valid consistent with the original English version. This version should help French-speaking clinicians and scientists document changes in patients with lumbar spinal stenosis.

Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada

Department of Human Kinetics, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada

Department of Chiropractic, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada.

Address correspondence and reprint requests to Andrée-Anne Marchand, DC, MSc, 3351 boulevard des Forges, Trois-Rivières, QC G9A 5H7, Canada; E-mail: andree-anne.marchand@uqtr.ca

Received 6 July, 2018

Revised 15 August, 2018

Accepted 10 September, 2018

The manuscript submitted does not contain information about medical device(s)/drug(s).

No funds were received in support of this work.

No relevant financial activities outside the submitted work.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.spinejournal.com).

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.